3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
Primary endpoint(s) modified
Also in this update: Start date pushed from Oct 1, 2026 to Oct 8, 2026
Beijing Tongren HospitalNot applicable NCT07854366 Registry history of NCT07854366 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Final enrollment: 74 participants (planned 100); Study completion date changed from estimate of Dec 31, 2027 to Sep 29, 2026
Beijing Tongren HospitalPhase 2 NCT07461831 Registry history of NCT07461831 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Beijing Tongren HospitalPhase 2 NCT04673643 Registry history of NCT04673643 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-02 | NCT07854366 SmoothCore Orthokeratology Plus M.O.V.E. Lenses vs. M.O.V.E. Lenses Alone for Myopia… | Not Yet Recruiting | |
| 2026-10-01 | NCT07851532 Screening for Hyperopic Reserve in Kindergarten | Recruiting | |
| 2026-10-01 | NCT07852234 Exploratory Study on the Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of… | Phase 2 | Not Yet Recruiting |
| 2026-09-30 | NCT07848763 Visual and Neural Responses to Naked-Eye 3-D Viewing | Completed | |
| 2026-09-16 | NCT07822776 Efgartigimod in Anti-NMDA Receptor Encephalitis. | Phase 2 | Recruiting |
| Phase 1 | 2 | |
| Phase 1/2 | 2 | |
| Phase 2 | 13 | |
| Phase 3 | 1 | |
| Phase 4 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07355699 | Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously… | Marginal Zone Lymphoma(MZL) | Recruiting | 2026-01-21 |
| NCT07679685 | Perfluorohexyloctane Eye Drops vs. Sodium Hyaluronate for Video Display… | Dry Eye | Not Yet Recruiting | 2026-07-01 |
| NCT06801353 | A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic… | Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) | Not Yet Recruiting | 2025-02-06 |
| Phase 3 | ||||
| NCT06102395 | Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the… | Head and Neck Squamous Cell Carcinoma | Recruiting | 2023-10-30 |
| Phase 2 | ||||
| NCT07822776 | Efgartigimod in Anti-NMDA Receptor Encephalitis. | Encephalitis Autoimmune | Recruiting | 2026-09-16 |
| NCT07499791 | Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis | Chronic Dacryocystitis | Recruiting | 2026-08-27 |
| NCT07523737 | Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory… | Primary Central Nervous System Lymphoma (PCNSL) | Recruiting | 2026-04-15 |
| NCT07371923 | Application of Zanubrutinib-based Combination Regimens in the Treatment of… | Diffuse Large B Cell Lymphoma (DLBCL) | Recruiting | 2026-01-28 |
| NCT06300203 | Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis | Seasonal Allergic Rhinitis | Recruiting | 2025-09-25 |
| NCT06725498 | Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC | Head and Neck Squamous Cell Carcinoma | Recruiting | 2024-12-10 |
| NCT06510283 | Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent… | Anti-N-Methyl-D-Aspartate Receptor Encephalitis | Recruiting | 2024-11-20 |
| NCT06100497 | Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced… | Head and Neck Squamous Cell Carcinoma | Recruiting | 2024-08-09 |
| NCT06081478 | CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute… | B-cell Acute Lymphoblastic Leukemia | Recruiting | 2023-10-13 |
| NCT07852234 | Exploratory Study on the Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of… | Primary Sjögren's Syndrome (pSS) | Not Yet Recruiting | 2026-10-01 |
| NCT07554482 | Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell… | Extranodal NK/T-cell Lymphoma | Not Yet Recruiting | 2026-04-28 |
| NCT06894459 | A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and… | Head and Neck Cancers | Not Yet Recruiting | 2025-04-30 |
| NCT06793761 | A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1… | Head and Neck Cancer | Not Yet Recruiting | 2025-01-27 |
| Phase 1/2 | ||||
| NCT07525466 | Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and… | Extranodal NK T Cell Lymphoma | Recruiting | 2026-04-13 |
| NCT06376721 | Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or… | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Recruiting | 2024-04-19 |
| Phase 1 | ||||
| NCT07040072 | Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC | HNSCC | Recruiting | 2026-05-04 |
| NCT05445063 | Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular… | Macular Degeneration | Recruiting | 2022-07-06 |
| Not applicable | ||||
| NCT07323251 | Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle… | Children With Myopia | Recruiting | 2026-01-07 |
| NCT06732622 | Laser Acupuncture for Idiopathic Bell's Palsy | Bell Palsy | Recruiting | 2024-12-13 |
| NCT06696625 | Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye | Dry Eye Disease | Recruiting | 2024-11-20 |
| NCT06468852 | GDFT on the Postoperative Outcome in Head and Neck Cancer Surgery | Postoperative Complications | Recruiting | 2024-06-21 |
Head & Neck Cancer (7) · Non-Hodgkin Lymphoma (7) · DLBCL (3) · Acute Lymphoblastic Leukemia (ALL) (2) · Diabetes (2) · Leukemia (2) · Anxiety (1) · Hypertension (1)